For EPHB4 we observed discordance in the effect direction based on the outcome, as higher EPHB4 expression was associated with greater WMH burden but lower AD risk, a trend that is also reflected at the protein (pQTL) level. Here, EPHB4 is linked to Alzheimer disease.